• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 11-K filed by Elevance Health Inc.

    6/17/26 1:58:21 PM ET
    $ELV
    Medical Specialities
    Health Care
    Get the next $ELV alert in real time by email
    elv-20251231
    false0001156039Elevance Health, Inc.11-Khttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#T.RowePriceMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#MFSMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#MFSMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#PrudentialMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#StateStreetMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#DoubleLineMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#VanguardMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#WestwoodMemberhttp://fasb.org/us-gaap/2026#OtherAggregatedInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberhttp://www.elevancehealth.com/20251231#JPMorganMemberhttp://fasb.org/us-gaap/2026#MiscellaneousInvestmentsMemberhttp://fasb.org/us-gaap-ebp/2026#EmployeeBenefitPlanParticipantDirectedMemberiso4217:USDxbrli:purexbrli:shares0001156039elv:EBP005Member2025-01-012025-12-3100011560392025-01-012025-12-310001156039elv:EBP005Member2025-12-310001156039elv:EBP005Member2024-12-310001156039elv:EBP005Membersrt:MinimumMember2025-01-012025-12-310001156039elv:EBP005Membersrt:MaximumMember2025-01-012025-12-310001156039elv:EBP005Memberelv:EBPEmployerMatchTrancheOneMember2025-01-012025-12-310001156039elv:EBP005Memberelv:EBPEmployerMatchTrancheTwoMember2025-01-012025-12-310001156039us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMemberelv:EBP005Member2025-12-310001156039us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMemberelv:EBP005Member2025-12-310001156039us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMemberelv:EBP005Member2024-12-310001156039us-gaap:DefinedBenefitPlanCommonCollectiveTrustMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMemberelv:EBP005Member2024-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMemberelv:EBP005Member2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMemberelv:EBP005Member2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMemberelv:EBP005Member2024-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMemberelv:EBP005Member2024-12-310001156039us-gaap:MutualFundMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMemberelv:EBP005Member2025-12-310001156039us-gaap:MutualFundMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMemberelv:EBP005Member2025-12-310001156039us-gaap:MutualFundMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMemberelv:EBP005Member2024-12-310001156039us-gaap:MutualFundMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMemberelv:EBP005Member2024-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMemberelv:EBP005Member2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMemberelv:EBP005Member2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMemberelv:EBP005Member2024-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMemberelv:EBP005Member2024-12-310001156039elv:EBP005Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember2025-12-310001156039elv:EBP005Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember2025-12-310001156039elv:EBP005Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember2024-12-310001156039elv:EBP005Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedPlanInterestInMasterTrustMember2024-12-310001156039elv:EBP005Memberus-gaap-ebp:EmployeeBenefitPlanNonconsolidatedMasterTrustMember2025-01-012025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberelv:EBP005Memberus-gaap:FairValueInputsLevel12And3Member2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberelv:EBP005Memberus-gaap:FairValueInputsLevel1Member2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberelv:EBP005Memberus-gaap:FairValueInputsLevel2Member2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberelv:EBP005Memberus-gaap:FairValueInputsLevel3Member2025-12-310001156039us-gaap:MutualFundMemberelv:EBP005Memberus-gaap:FairValueInputsLevel12And3Member2025-12-310001156039us-gaap:MutualFundMemberelv:EBP005Memberus-gaap:FairValueInputsLevel1Member2025-12-310001156039us-gaap:MutualFundMemberelv:EBP005Memberus-gaap:FairValueInputsLevel2Member2025-12-310001156039us-gaap:MutualFundMemberelv:EBP005Memberus-gaap:FairValueInputsLevel3Member2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberelv:EBP005Memberus-gaap:FairValueInputsLevel12And3Member2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberelv:EBP005Memberus-gaap:FairValueInputsLevel1Member2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberelv:EBP005Memberus-gaap:FairValueInputsLevel2Member2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberelv:EBP005Memberus-gaap:FairValueInputsLevel3Member2025-12-310001156039elv:EBP005Memberus-gaap:FairValueInputsLevel12And3Member2025-12-310001156039elv:EBP005Memberus-gaap:FairValueInputsLevel1Member2025-12-310001156039elv:EBP005Memberus-gaap:FairValueInputsLevel2Member2025-12-310001156039elv:EBP005Memberus-gaap:FairValueInputsLevel3Member2025-12-310001156039elv:EBP005Memberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2025-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberelv:EBP005Memberus-gaap:FairValueInputsLevel12And3Member2024-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberelv:EBP005Memberus-gaap:FairValueInputsLevel1Member2024-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberelv:EBP005Memberus-gaap:FairValueInputsLevel2Member2024-12-310001156039us-gaap-ebp:EmployeeBenefitPlanEmployerCommonStockMemberelv:EBP005Memberus-gaap:FairValueInputsLevel3Member2024-12-310001156039us-gaap:MutualFundMemberelv:EBP005Memberus-gaap:FairValueInputsLevel12And3Member2024-12-310001156039us-gaap:MutualFundMemberelv:EBP005Memberus-gaap:FairValueInputsLevel1Member2024-12-310001156039us-gaap:MutualFundMemberelv:EBP005Memberus-gaap:FairValueInputsLevel2Member2024-12-310001156039us-gaap:MutualFundMemberelv:EBP005Memberus-gaap:FairValueInputsLevel3Member2024-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberelv:EBP005Memberus-gaap:FairValueInputsLevel12And3Member2024-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberelv:EBP005Memberus-gaap:FairValueInputsLevel1Member2024-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberelv:EBP005Memberus-gaap:FairValueInputsLevel2Member2024-12-310001156039us-gaap-ebp:EmployeeBenefitPlanSelfDirectedBrokerageAccountMemberelv:EBP005Memberus-gaap:FairValueInputsLevel3Member2024-12-310001156039elv:EBP005Memberus-gaap:FairValueInputsLevel12And3Member2024-12-310001156039elv:EBP005Memberus-gaap:FairValueInputsLevel1Member2024-12-310001156039elv:EBP005Memberus-gaap:FairValueInputsLevel2Member2024-12-310001156039elv:EBP005Memberus-gaap:FairValueInputsLevel3Member2024-12-310001156039elv:EBP005Memberus-gaap:FairValueMeasuredAtNetAssetValuePerShareMember2024-12-310001156039elv:EBP005Memberus-gaap:RelatedPartyMember2025-01-012025-12-310001156039elv:EBP005Memberus-gaap:RelatedPartyMember2025-12-310001156039elv:EBP005Memberus-gaap:RelatedPartyMember2024-12-310001156039elv:EBP005Member2022-01-012022-12-310001156039elv:EBP005Member2023-01-012023-12-310001156039elv:EBP005MemberVanguard Institutional 500 Index Trust2025-01-012025-12-310001156039elv:EBP005MemberVanguard Institutional 500 Index Trust2025-12-310001156039elv:EBP005MemberT. Rowe Price Large-Cap Growth Trust2025-01-012025-12-310001156039elv:EBP005MemberT. Rowe Price Large-Cap Growth Trust2025-12-310001156039elv:EBP005MemberMFS Large Cap Value CIT Class 52025-01-012025-12-310001156039elv:EBP005MemberMFS Large Cap Value CIT Class 52025-12-310001156039elv:EBP005MemberMFS International Equity Fund Class 3A2025-01-012025-12-310001156039elv:EBP005MemberMFS International Equity Fund Class 3A2025-12-310001156039elv:EBP005MemberPrudential Core Plus Bond Fund Class 52025-01-012025-12-310001156039elv:EBP005MemberPrudential Core Plus Bond Fund Class 52025-12-310001156039elv:EBP005MemberVanguard Inst Extended Mkt Index Trust2025-01-012025-12-310001156039elv:EBP005MemberVanguard Inst Extended Mkt Index Trust2025-12-310001156039elv:EBP005MemberVanguard Inst Total Bond Mkt Index Trust2025-01-012025-12-310001156039elv:EBP005MemberVanguard Inst Total Bond Mkt Index Trust2025-12-310001156039elv:EBP005MemberState Street Real Asset Fund Class C2025-01-012025-12-310001156039elv:EBP005MemberState Street Real Asset Fund Class C2025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2020 Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2020 Fund2025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2025 Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2025 Fund2025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2030 Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2030 Fund2025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2035 Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2035 Fund2025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2040 Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2040 Fund2025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2045 Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2045 Fund2025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2050 Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2050 Fund2025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2055 Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2055 Fund2025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2060 Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2060 Fund2025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2065 Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2065 Fund2025-12-310001156039elv:EBP005MemberVanguard Explorer Fund; Admiral Shares Mutual FundVanguard Total International Stock Index Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Total International Stock Index Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Total International Stock Index Fund2025-12-310001156039elv:EBP005MemberVanguard Explorer Fund; Admiral Shares Mutual Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Explorer Fund; Admiral Shares Mutual Fund2025-12-310001156039elv:EBP005MemberDoubleLine Flexible Income Fund Class I2025-01-012025-12-310001156039elv:EBP005MemberDoubleLine Flexible Income Fund Class I2025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2070 Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement 2070 Fund2025-12-310001156039elv:EBP005MemberVanguard Target Retirement Income Fund2025-01-012025-12-310001156039elv:EBP005MemberVanguard Target Retirement Income Fund2025-12-310001156039elv:EBP005MemberWestwood Quality SmallCap Fund; Ultra2025-01-012025-12-310001156039elv:EBP005MemberWestwood Quality SmallCap Fund; Ultra2025-12-310001156039elv:EBP005MemberJP Morgan2025-12-310001156039elv:EBP005MemberJP Morgan2025-01-012025-12-31

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM 11-K
    (Mark One)
    ☒ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the fiscal year ended December 31, 2025
    OR
    oTRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
    For the transition period from ________to_________
    Commission file number: 001-16751 
     
    A.Full title of the plan and the address of the plan, if different from that of the issuer named below:
    ELEVANCE HEALTH PUERTO RICO RETIREMENT PLAN
    B.Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:
    Elevance Health, Inc.
    220 Virginia Avenue
    Indianapolis, IN 46204



    REQUIRED INFORMATION
    The Elevance Health Puerto Rico Retirement Plan (the “Plan”) is subject to the Employee Retirement Income Security Act of 1974, as amended (“ERISA”). In lieu of the requirements of Items 1-3 of Form 11-K, the financial statements of the Plan and the supplemental schedules presented herein have been prepared in accordance with the financial reporting requirements of ERISA.


    1


    ELEVANCE HEALTH PUERTO RICO RETIREMENT PLAN
    Financial Statements and Supplemental Schedules
    December 31, 2025 and 2024 and for the
    Year Ended December 31, 2025
    With Report of Independent Registered Public Accounting Firm



    ELEVANCE HEALTH PUERTO RICO RETIREMENT PLAN
    Financial Statements and Supplemental Schedules
    December 31, 2025 and 2024 and for the
    Year Ended December 31, 2025
    Contents
     Page
    Report of Independent Registered Public Accounting Firm
    4 
    Audited Financial Statements:
    Statements of Net Assets Available for Benefits
    5 
    Statement of Changes in Net Assets Available for Benefits
    6 
    Notes to Financial Statements
    7 
    Supplemental Schedules:
    Schedule H, Line 4a – Schedule of Delinquent Participant Contributions
    15 
    Schedule H, Line 4i – Schedule of Assets (Held at End of Year)
    16 



    3


    Report of Independent Registered Public Accounting Firm
    To the Plan Participants and the Plan Administrator of Elevance Health Puerto Rico Retirement Plan

    Opinion on the Financial Statements

    We have audited the accompanying statements of net assets available for benefits of Elevance Health Puerto Rico Retirement Plan (the Plan) as of December 31, 2025 and 2024, and the related statement of changes in net assets available for benefits for the year ended December 31, 2025, and the related notes (collectively referred to as the “financial statements”). In our opinion, the financial statements present fairly, in all material respects, the net assets available for benefits of the Plan at December 31, 2025 and 2024, and the changes in its net assets available for benefits for the year ended December 31, 2025, in conformity with U.S. generally accepted accounting principles.
    Basis for Opinion
    These financial statements are the responsibility of the Plan’s management. Our responsibility is to express an opinion on the Plan’s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Plan in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.
    We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Plan is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Plan’s internal control over financial reporting. Accordingly, we express no such opinion.
    Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.
    Supplemental Schedules Required by ERISA
    The accompanying supplemental schedules of assets (held at end of year) as of December 31, 2025, and delinquent participant contributions for the year then ended (referred to as the “supplemental schedules”), have been subjected to audit procedures performed in conjunction with the audit of the Plan’s financial statements. The information in the supplemental schedules is the responsibility of the Plan’s management. Our audit procedures included determining whether the information reconciles to the financial statements or the underlying accounting and other records, as applicable, and performing procedures to test the completeness and accuracy of the information presented in the supplemental schedules. In forming our opinion on the information, we evaluated whether such information, including its form and content, is presented in conformity with the Department of Labor’s Rules and Regulations for Reporting and Disclosure under the Employee Retirement Income Security Act of 1974. In our opinion, the information is fairly stated, in all material respects, in relation to the financial statements as a whole.
    /s/ Ernst & Young LLP
    We have served as the Plan’s auditor since 2024.
    Indianapolis, Indiana

    June 17, 2026


    4


    Elevance Health Puerto Rico Retirement Plan
    Statements of Net Assets Available for Benefits
     December 31
     
    2025
    2024
    Assets
    Investments at fair value$125,000,456 $92,579,724 
    Plan's interest in EH Master Trust
    1,687,627 1,476,972 
    Total investments at fair value
    126,688,083 94,056,696 
    Receivables:
    Notes receivable from participants4,905,765 3,461,084 
    Contributions receivable from employer237,317 185,093 
    Total receivables5,143,082 3,646,177 
    Net assets available for benefits$131,831,165 $97,702,873 
    See Notes to Financial Statements.



    5


    Elevance Health Puerto Rico Retirement Plan
    Statement of Changes in Net Assets Available for Benefits
    Year Ended December 31, 2025
    Additions to net assets attributable to
    Contributions:
    Participants$11,151,923 
    Employer7,610,287 
    Rollovers1,719,230 
                 Total contributions20,481,440 
    Net appreciation in fair value of investments15,532,250 
    Interest and dividends3,280,954 
    Plan's interest in EH Master Trust net investment income
    53,469 
    Interest income on notes receivable from participants325,017 
                Total additions39,673,130 
    Deductions from net assets attributable to
    Benefits paid to participants5,335,474 
    Administrative expenses209,364 
                Total deductions5,544,838 
    Increase in net assets available for benefits34,128,292 
    Net assets available for benefits
    Beginning of year97,702,873 
    End of year$131,831,165 
    See Notes to Financial Statements.



    6


    Elevance Health Puerto Rico Retirement Plan
    Notes to Financial Statements
    December 31, 2025
    1. Description of the Plan
    The following description of the Elevance Health Puerto Rico Retirement Plan (the “Plan”) provides only general information. More detailed information concerning the Plan may be found by consulting the summary plan description.
    General
    The Plan is a Puerto Rico qualified defined contribution plan which provides savings opportunities for eligible employees of The Elevance Health Companies of Puerto Rico, LLC and certain of its subsidiaries ("Participating Employers") who work in Puerto Rico and is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended ("ERISA"). Employees of the Participating Employers are generally eligible to participate in the Plan 30 days after their date of hire.

    The Plan was originally established on January 1, 2011 as The MMM Holdings, Inc. 1081.01 Retirement Plan and Trust (the "Predecessor Plan"). On September 19, 2023, sponsorship of the Plan was transferred to ATH Holding Company, LLC ("Plan Sponsor"), a wholly owned subsidiary of Elevance Health, Inc. ("Elevance Health"), and the administrator and named fiduciary of the Plan was changed from the MMM Holdings Retirement Savings Plan Retirement Plan Committee to the Retirement Committee of ATH Holding Company, LLC. The Predecessor Plan was amended and restated in its entirety effective January 1, 2024, to convert the Predecessor Plan from a prototype plan to an individually designed plan and to change the name to the Elevance Health Puerto Rico Retirement Plan.

    The Plan participates in the Elevance Health Defined Contribution Master Trust (the "EH Master Trust") solely with respect to the Plan's investments in the Elevance Health Stock Fund and a stable value collective investment trust fund. Oriental Bank and Trust serves as the trustee for all Plan investments. Fidelity Management Trust Company serves as the agent and custodian of the Plan and Fidelity Workplace Services LLC serves as the recordkeeper (collectively, "Fidelity").
    Participant Accounts
    An individual account is maintained by the Plan for each eligible employee who participates in the Plan. Each participant’s account is credited with the participant’s contributions, rollover contributions, allocations of the Plan Sponsor’s contributions, and an allocation of investment earnings or losses, reduced by participant withdrawals and certain administrative expenses. The benefit to which a participant is entitled is the benefit that can be provided from the participant’s account.
    Contributions
    Participants may make voluntary pretax contributions of 1% to 80% of eligible compensation, as defined in the Plan document, subject to limitations imposed by the Puerto Rico Internal Revenue Code of 2011 (the "PR Code”). Participants are automatically enrolled in the Plan at an initial pretax deferral rate of 6%, with an annual automatic increase of the rate of 1%, up to 15% of the participant's eligible compensation, unless the participant directs otherwise. Annual pretax contributions could not individually exceed $15,000 in 2025 under the PR Code.
    Under the Predecessor Plan, participants were permitted to make after-tax contributions, but such contributions were not permitted after December 31, 2023.
    The Plan Sponsor provides a matching contribution of 100% on the first 4% of the participant's eligible compensation, plus 50% of the next 2% of the participant's eligible compensation contributed, for a total potential Plan Sponsor matching contribution of 5%. Additionally, the Plan provides for a true-up matching contribution to ensure that eligible participants who elected to contribute the maximum contribution allowed by the Plan receive the


    7


    Elevance Health Puerto Rico Retirement Plan
    Notes to Financial Statements (continued)
    maximum matching contribution of eligible compensation determined as of the end of the plan year. The Plan permits additional Plan Sponsor discretionary contributions to be made, but no such discretionary contributions were made during the 2025 plan year.
    Participants who attain age 50 by the end of the plan year may contribute additional "catch up" contributions to their account beyond the annual PR Code limitation up to $1,500 in 2025, in accordance with applicable law and the Plan's terms. Catch-up contributions are eligible for matching contributions.
    Rollover Contributions
    The Plan may accept rollover contributions. Rollover contributions represent distributions received from other Puerto Rico qualified retirement plans. Distributions from other plans are subject to certain conditions to be eligible for rollover into the Plan.
    Vesting
    Participants have a 100% vested interest in the Plan Sponsor match after completing a two-year period of service. Nonvested account balances of terminated employees are forfeited (subject to reinstatement upon reemployment as required by applicable law and the Plan's terms).
    Investments
    Participants direct their elective contributions and employer matching contributions into various investment options offered by the Plan, including target date funds, several mutual and collective investment trust funds, all of which are subject to change from time to time by the Plan Administrator, and the Elevance Health Stock Fund, which is provided for in the Plan document and overseen by an independent fiduciary. If a participant has not elected an investment option, their contributions will automatically be invested in the Plan’s qualified default investment alternative, which is the target date fund aligned with the year the participant turns 65.
    The Elevance Health Stock Fund is a unitized fund, which means participants do not actually own shares of Elevance Health common stock but rather own an interest in the unitized fund. A portion of the fund may be invested in short-term reserves to accommodate daily transactions. Investment in the Elevance Health Stock Fund is limited to no more than 20% of a participant's total account balance. Each participant is entitled to exercise voting rights attributable to the shares allocated to his or her account. Any cash dividends paid to the participant’s account will be reinvested in the Elevance Health Stock Fund unless the participant elects to receive the dividend in cash paid directly to the participant. Participants may change their election to receive dividends in cash or to reinvest dividends at least quarterly.
    Benefit Payments and Withdrawals
    A participant may make a withdrawal from any after-tax contributions made to the Predecessor Plan for any reason, including income attributable to such account. After attaining age 59½, a participant may withdraw participant and Plan Sponsor matching contributions for any reason.
    Subject to the provisions and conditions specified in the Plan document, an active participant in the Plan may make certain hardship withdrawals of amounts held in the participant’s account attributable to the participant’s contributions, vested Plan Sponsor matching contributions, rollovers, pre-2006 employer match, and income allocated to the contributions account.
    Upon termination of employment, the participant is entitled to receive the fully vested current value of his or her account. If the current value of the vested account is $5,000 or less, the account is paid in a lump-sum payment. If the vested account value is $5,000 or more, the account will remain in the Plan unless the participant elects otherwise. The participant may elect to have the entire portion, if any, of the account held in the Elevance Health Stock Fund paid in whole shares of Elevance Health common stock, with fractional shares and any uninvested funds paid in cash. Distribution of participant accounts must commence not later than 60 days after the close of the plan year in which the latest of the following occurs: (i) the participant attains normal retirement age; (ii) the tenth anniversary of the commencement of the participant's participation in the Plan; and (iii) the participant's termination


    8


    Elevance Health Puerto Rico Retirement Plan
    Notes to Financial Statements (continued)
    of employment. Upon death, payments are made to the participant’s beneficiary in the form of a lump-sum payment or in installments.
    Notes Receivable from Participants
    Participants may request a loan not in excess of the lesser of: (1) 50% of the vested account balance, or (2) $50,000, less the highest outstanding loan balance during the preceding year. A participant may not have more than two loans outstanding at any one time and must wait 30 days from when a loan is paid off before requesting a new loan. Repayment of loans shall not exceed five years, except for loans used to acquire the participant’s principal residence. Each loan bears interest in accordance with the Plan's loan policy and applicable regulations. Repayments are made by payroll deduction or remitted directly to Fidelity.

    Forfeitures
    Forfeited nonvested account balances totaled $36,078 and $90,558 as of December 31, 2025 and 2024, respectively. Forfeitures may be used to offset employer contributions or to pay certain administrative expenses. During the year ended December 31, 2025, forfeitures of $161,014 were used to offset employer contributions and forfeitures of $123,517 were used to pay administrative expenses.
    Plan Termination    
    Although it has not expressed any intent to do so, the Plan Sponsor has the right to terminate the Plan subject to the terms of the Plan and the provisions of ERISA. In the event the Plan is terminated, each participant’s account shall be non-forfeitable with respect to both the participant’s and the Plan Sponsor’s contributions. The Plan Sponsor has the right to amend the Plan or to suspend matching contributions to the Plan at any time, either permanently or temporarily, for any length of time.
    2. Significant Accounting Policies
    Basis of Presentation
    The accompanying financial statements of the Plan have been prepared on the accrual basis of accounting and are in conformity with U.S. generally accepted accounting principles (“GAAP”).
    Use of Estimates
    The preparation of financial statements in accordance with GAAP requires the use of estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results may differ from those estimates.
    Investment Valuation and Income Recognition
    The Plan's and the EH Master Trust's investments are stated at fair value. Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. See Note 4, "Fair Value Measurements", for further discussion.
    The Plan's interest in the net investment income of the EH Master Trust consists of the Plan's allocation of realized gains and losses on investments that were sold during the period, unrealized appreciation and depreciation of the underlying investments held at year end, and net investment income/loss based upon the total of each Plan participant's share of the EH Master Trust.
    Purchases and sales of securities are recorded on a trade-date basis and interest income is recorded on the accrual basis. Dividends are recorded on the ex-dividend date. Net appreciation or depreciation in fair value of investments includes realized gains and losses on investments that were sold during the period as well as unrealized appreciation or depreciation of the investments held at year end.


    9


    Elevance Health Puerto Rico Retirement Plan
    Notes to Financial Statements (continued)
    Investment securities are exposed to various risks, such as interest rate, market, and credit risks. Due to the level of risk associated with certain investment securities, it is reasonably possible that changes in the values of investment securities will occur in the near term and that such changes could materially affect the amounts reported in the statements of net assets available for benefits, participant accounts and the statement of changes in net assets available for benefits.

    Notes Receivable from Participants
    Notes receivable from participants represent participant loans that are recorded at their unpaid principal balance plus any accrued but unpaid interest. Interest income on notes receivable from participants is recorded when it is earned. Related fees are recorded as administrative expenses and are expensed when they are incurred. Delinquent participant loans are recorded as distributions based on the terms of the Plan document. No allowance for credit losses has been recorded as of December 31, 2025 or 2024.
    Benefits Paid to Participants
    Benefit payments to participants are recorded upon distribution.
    Administrative Expenses
    Certain expenses of maintaining the Plan are paid from Plan assets. The Plan Sponsor may bear certain costs associated with administering the Plan; these costs are not included in the accompanying financial statements and constitute exempt party-in-interest transactions. Certain transaction fees, such as those related to loan processing, are paid from individual participant accounts and are included in administrative expenses. Investment related expenses are included in both the Plan's interest in EH Master Trust net investment income and in net appreciation or depreciation in fair value of investments.
    Recently Adopted Accounting Pronouncements
    There have been no recently adopted or issued accounting standards that had, or will have, a material impact on the financial statements.
    3. Plan's Interest in EH Master Trust
    The Elevance Health Defined Contribution Master Trust was established on January 1, 2024 pursuant to a trust agreement between the Plan Administrator and Fidelity in order to facilitate the administration of transactions in the Elevance Health Stock Fund and a stable value collective investment trust fund offered in both this Plan and the Elevance Health 401(k) Plan (together, the "Participating Plans"). Each Participating Plan has a divided interest in specific investment assets held in the EH Master Trust.









    10


    Elevance Health Puerto Rico Retirement Plan
    Notes to Financial Statements (continued)
    A summary of the net assets of the EH Master Trust and the Plan's interest in the net assets of the EH Master Trust as of December 31, 2025 is as follows:
    20252024
    EH Master Trust Balances
    Plan's Interest in EH Master Trust Balances
    EH Master Trust Balances
    Plan's Interest in EH Master Trust Balances
    Investments at fair value
    Collective investment trusts$12,095,039,709 $1,571,637 $10,874,772,817 $1,436,468 
    Elevance Health common stock352,309,761 115,007 408,045,086 40,155 
    Mutual funds302,657,683 1,004 329,248,156 352 
    Self-directed brokerage accounts316,803,497 — 250,803,504 — 
    Total investments at fair value
    13,066,810,650 1,687,648 11,862,869,563 1,476,975 
    Other assets (liabilities)(64,169)(21)(37,723)(3)
    Total net assets$13,066,746,481 $1,687,627 $11,862,831,840 $1,476,972 
    During the year ended December 31, 2025, the EH Master Trust net investment income was comprised of the following:
    2025
    EH Master Trust Balances
    Net appreciation in fair value of investments$1,774,360,282 
    Interest and dividends43,516,628 
    Total EH Master Trust net investment income
    $1,817,876,910 
    4. Fair Value Measurements
    The framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. Level inputs, as defined by the Financial Accounting Standards Board guidance for fair value measurements and disclosures, are as follows: Level 1, inputs are unadjusted, quoted prices for identical assets or liabilities in active markets at the measurement date; Level 2, inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration with market data; and Level 3, unobservable inputs that reflect management's best estimate of what market participants would use in pricing the asset or liability. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.
    The following methods and assumptions were used to determine the fair value of investments recorded at fair value in the statements of net assets available for benefits.
    Elevance Health common stock: Valued at the closing price on the New York Stock Exchange on the last business day of the plan year.
    Mutual funds: Valued at quoted market prices, which represent net asset value ("NAV") of shares held by the Plan.
    Collective investment trusts (CITs): Valued based on the NAV of the units of a collective trust. The NAV, as provided by the trustee, is used as a practical expedient to estimate fair value. The NAV is based on the fair value of the underlying investments held by the trust less its liabilities. There are no restrictions on redemptions from the CITs and no unfunded commitments.


    11


    Elevance Health Puerto Rico Retirement Plan
    Notes to Financial Statements (continued)
    The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December 31, 2025:
    December 31, 2025TotalLevel 1Level 2Level 3
    Elevance Health common stock$352,309,761 $352,309,761 $— $— 
    Mutual funds302,657,683 302,657,683 — — 
    Self-directed brokerage accounts316,803,497 312,048,032 4,544,392 211,073 
    Investments measured at fair value971,770,941 967,015,476 4,544,392 211,073 
    Investments measured at NAV12,095,039,709 
    Total investments at fair value$13,066,810,650 
    The following table sets forth by level within the fair value hierarchy a summary of the EH Master Trust investments by general types measured at fair value on a recurring basis as of December 31, 2024:
    December 31, 2024TotalLevel 1Level 2Level 3
    Elevance Health common stock$408,045,086 $408,045,086 $— $— 
    Mutual funds329,248,156 329,248,156 — — 
    Self-directed brokerage accounts250,803,504 246,848,476 3,920,987 34,041 
    Investments measured at fair value988,096,746 984,141,718 3,920,987 34,041 
    Investments measured at NAV10,874,772,817 
    Total investments at fair value$11,862,869,563 
    Our Level 3 securities as of December 31, 2025 and December 31, 2024 primarily consisted of certain corporate fixed maturity securities for which observable inputs were not always available. The fair values of these securities were estimated using inputs including, but not limited to, credit spreads, default rates and benchmark yields. There were no material transfers in or out of Level 3 during either the year ended December 31, 2025 or the year ended December 31, 2024.
    The following table sets forth by level within the fair value hierarchy a summary of the Plan's investments by general types measured at fair value on a recurring basis as of December 31, 2025:
    December 31, 2025TotalLevel 1Level 2Level 3
    Mutual funds$114,074,239 $114,074,239 $— $— 
    Investments measured at fair value114,074,239 114,074,239 — — 
    Investments measured at NAV10,926,217 
    Total investments at fair value$125,000,456 
    The following table sets forth by level within the fair value hierarchy a summary of the Plan's investments measured at fair value on a recurring basis as of December 31, 2024:
    December 31, 2024TotalLevel 1Level 2Level 3
    Mutual funds$84,682,391 $84,682,391 $— $— 
    Investments measured at fair value84,682,391 84,682,391 — — 
    Investments measured at NAV7,897,333 
    Total investments at fair value$92,579,724 




    12


    Elevance Health Puerto Rico Retirement Plan
    Notes to Financial Statements (continued)
    5. Exempt Related Party and Party-In-Interest Transactions
    Parties-in-interest are defined under Department of Labor ("DOL") regulations as any fiduciary of the Plan, any party rendering services to the Plan, the employer, and certain others. Certain administrative functions are performed by officers and employees of the Plan Sponsor or affiliates of the Plan Sponsor. No such officer or employee is compensated from the Plan.
    During the year ended December 31, 2025, the Plan reimbursed the Plan Sponsor $60,000 for administrative expenses. This reimbursement is included in administrative expenses in the statement of changes in net assets available for benefits.
    Transactions in shares of Elevance Health common stock qualify as exempt party-in-interest transactions under the provisions of ERISA. The Plan owned approximately 328 and 109 shares of Elevance Health common stock as of December 31, 2025 and December 31, 2024, respectively. During the year ended December 31, 2025, the Plan had net purchases of Elevance Health common stock totaling $72,608 and the total dividends on Elevance Health common stock in the Elevance Health Stock Fund were $2,334.
    Certain Plan investments include funds that are managed by affiliates of Fidelity, which constitute party-in-interest transactions.
    Notes receivable from participants also reflect exempt party-in-interest transactions.
    6. Non-Exempt Related Party and Party-In-Interest Transactions
    It was discovered that, during the plan years ended December 31, 2022 and 2023, participant contributions and loan repayments to the Predecessor Plan, totaling $1,098,317 and $1,940,849, respectively, inadvertently not timely deposited. As a correction, during the year ended December 31, 2025, the plan sponsor credited affected participant accounts with the amount of investment income that would have been earned had those participant contributions and loan repayments been timely deposited.
    7. Income Tax Status
    The Plan received a favorable determination letter from the Puerto Rico Department of Treasury dated September 18, 2025, effective January 1, 2024, stating the Plan is qualified under Section 1081.01 of the PR Code and, therefore, exempt from Puerto Rico income taxation. Although the Plan has been amended since receiving the determination letter, the Plan Sponsor believes the Plan is designed and being operated in compliance with the applicable requirements of the PR Code. The EH Master Trust is intended to be exempt from Puerto Rico income taxation pursuant to the provisions of Section 1081.01(a) of the PR Code. In addition, pursuant to Section 1022(i)(1) of ERISA, the Plan's EH Master Trust is intended to be treated, for purposes of Section 501(a) of the United States Internal Revenue Code ( the "US Code"), as an organization described in Section 401(a) of the US Code and therefore exempt from United States income taxation under Section 501(a) of the US Code.

    GAAP requires Plan management to evaluate tax positions taken by the Plan and recognize a tax liability if the Plan has taken an uncertain position that more likely than not would not be sustained upon examination by the Puerto Rico Treasury. Plan management has analyzed the tax positions taken by the Plan, and has concluded there are no uncertain tax positions taken or expected to be taken. The Plan is subject to routine audits by taxing jurisdictions; however, there are currently no audits for any tax periods in progress.






    13



    8. Reconciliation to Form 5500
    Reconciliation of net assets available for benefits per the financial statements to the Form 5500 as of December 31, 2025 and 2024, is as follows:
    20252024
    Net assets available for benefits per the financial statements$131,831,165 $97,702,873 
    Less: deemed distributions of participant loans
    13,595 60,074 
    Net assets available for benefits per the Form 5500$131,817,570 $97,642,799 
    Reconciliation of the increase in net assets available for benefits per the financial statements to the net income (loss) per the Form 5500 for the year ended December 31, 2025 is as follows:
    2025
    Increase in net assets available for benefits per the financial statements$34,128,292 
    Deemed distributions activity46,479 
    Net income (loss) per the Form 5500$34,174,771 
    9. Subsequent Events
    The Plan Sponsor has evaluated the impact of subsequent events through June 17, 2026, the date the financial statements were issued. No subsequent events have been recognized or required additional disclosure in the financial statements.


    14


    Elevance Health Puerto Rico Retirement Plan
    Schedule H, Line 4a—Schedule of Delinquent Participant Contributions
    Plan Sponsor: ATH Holding Company, LLC. EIN #11-3713086 Plan #005
    For the Year Ended December 31, 2025

    Participant Contributions Transferred Late to PlanTotal That Constitute Nonexempt Prohibited TransactionsTotal Fully Corrected Under Voluntary Fiduciary Correction Program (VFCP) and Prohibited Transaction Exemption 2002-51
    Plan YearCheck Here If Late Participant Loan Repayments Are IncludedContributions Not CorrectedContributions Corrected Outside of VFCPContributions Pending Correction in VFCP
    x
    2022$1,098,317 $— $1,098,317 $— $— 
    2023$1,940,849 $— $1,940,849 $— $— 























    15


    Elevance Health Puerto Rico Retirement Plan
    Schedule H, Line 4i—Schedule of Assets (Held at End of Year)
    Plan Sponsor: ATH Holding Company, LLC. EIN #11-3713086 Plan #005
    December 31, 2025
    (a)(b)(c)(d)(e)
     Identity of issuer, borrower,
    lessor, or similar party
    Description of investment including maturity date, interest rate, collateral and par or maturity valueCost**Current
    value
    Vanguard Institutional 500 Index TrustCIT32,394 shares— $4,505,702 
    T. Rowe Price Large-Cap Growth Trust
    CIT
    98,110 shares— 2,696,056 
    MFS Large Cap Value CIT Class 5
    CIT
    22,059 shares— 1,222,757 
    MFS International Equity Fund Class 3A
    CIT
    39,402 shares— 898,762 
    Prudential Core Plus Bond Fund Class 5
    CIT
    3,157 shares— 635,919 
    Vanguard Inst Extended Mkt Index Trust
    CIT
    3,117 shares— 401,011 
    Vanguard Inst Total Bond Mkt Index Trust
    CIT
    3,123 shares— 344,084 
    State Street Real Asset Fund Class C
    CIT
    10,815 shares— 221,926 
    $10,926,217
    Vanguard Target Retirement 2020 FundMutual fund23,962 shares— $657,748
    Vanguard Target Retirement 2025 FundMutual fund282,345 shares— 5,632,783 
    Vanguard Target Retirement 2030 FundMutual fund271,166 shares— 11,478,448 
    Vanguard Target Retirement 2035 FundMutual fund598,042 shares— 16,374,391 
    Vanguard Target Retirement 2040 FundMutual fund459,412 shares— 22,947,637 
    Vanguard Target Retirement 2045 FundMutual fund696,736 shares— 24,204,622 
    Vanguard Target Retirement 2050 FundMutual fund244,958 shares— 14,521,130 
    Vanguard Target Retirement 2055 FundMutual fund156,582 shares— 10,359,471 
    Vanguard Target Retirement 2060 FundMutual fund70,274 shares— 4,285,293 
    Vanguard Target Retirement 2065 FundMutual fund35,709 shares— 1,429,444 
    Vanguard Total International Stock Index FundMutual fund3,847 shares— 623,760 
    Vanguard Explorer Fund; Admiral SharesMutual fund4,020 shares— 428,922 
    DoubleLine Flexible Income Fund Class IMutual fund48,798 shares— 427,468 
    Vanguard Target Retirement 2070 FundMutual fund10,409 shares— 331,206 
    Vanguard Target Retirement Income FundMutual fund15,343 shares— 212,809 
    Westwood Quality SmallCap Fund; UltraMutual fund8,330 shares— 159,107 
    $114,074,239
    *JP MorganPlan's interest in EH Master Trust— $1,687,627
    *Notes receivable from participantsInterest rates range from3.25%to9.50%$4,892,170
    maturing at various dates through4/3/2040

    * Party-in-interest
    ** Historical cost is not required as all investments are participant-directed



    16


    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the Retirement Committee of ATH Holding Company, LLC has duly caused this annual report to be signed on its behalf by the undersigned hereunto duly authorized.
    ELEVANCE HEALTH PUERTO RICO RETIREMENT PLAN
    By:/s/ Ronald W. Penczek
    Ronald W. Penczek
    Member, Retirement Committee
    of ATH Holding Company, LLC
    Date: June 17, 2026



    17


    EXHIBIT INDEX
    Exhibit NumberDescription
    23Consent of Independent Registered Public Accounting Firm











    18
    Get the next $ELV alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ELV

    DatePrice TargetRatingAnalyst
    5/20/2026$498.00Hold → Buy
    Deutsche Bank
    4/29/2026$435.00Neutral → Buy
    BofA Securities
    4/8/2026$345.00In-line
    Evercore ISI
    2/3/2026$358.00Outperform → Sector Perform
    RBC Capital Mkts
    1/8/2026$425.00Peer Perform → Outperform
    Wolfe Research
    12/19/2025$320.00Buy → Hold
    Deutsche Bank
    10/14/2025Neutral
    Goldman
    7/21/2025Buy → Hold
    Argus
    More analyst ratings

    $ELV
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Elevance Health upgraded by Deutsche Bank with a new price target

    Deutsche Bank upgraded Elevance Health from Hold to Buy and set a new price target of $498.00

    5/20/26 8:03:29 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health upgraded by BofA Securities with a new price target

    BofA Securities upgraded Elevance Health from Neutral to Buy and set a new price target of $435.00

    4/29/26 8:00:15 AM ET
    $ELV
    Medical Specialities
    Health Care

    Evercore ISI initiated coverage on Elevance Health with a new price target

    Evercore ISI initiated coverage of Elevance Health with a rating of In-line and set a new price target of $345.00

    4/8/26 8:36:16 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    SEC Filings

    View All

    SEC Form 11-K filed by Elevance Health Inc.

    11-K - Elevance Health, Inc. (0001156039) (Filer)

    6/17/26 1:58:21 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form 11-K filed by Elevance Health Inc.

    11-K - Elevance Health, Inc. (0001156039) (Filer)

    6/17/26 1:57:10 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Inc. filed SEC Form 8-K: Regulation FD Disclosure

    8-K - Elevance Health, Inc. (0001156039) (Filer)

    6/10/26 6:01:35 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Collis Steven H bought $869,520 worth of shares (3,000 units at $289.84), increasing direct ownership by 469% to 3,639 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    3/6/26 8:03:27 AM ET
    $ELV
    Medical Specialities
    Health Care

    Director Devore Susan D. bought $374,580 worth of shares (1,200 units at $312.15), increasing direct ownership by 52% to 3,502 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    8/21/25 4:20:38 PM ET
    $ELV
    Medical Specialities
    Health Care

    President and CEO Boudreaux Gail bought $2,438,951 worth of shares (8,500 units at $286.94), increasing direct ownership by 6% to 151,020 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    7/18/25 1:42:51 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Elevance Health Makes Clinical Review Faster, More Connected with Health OS

    Elevance Health today announced advancements in how it helps streamline clinical review and create a simpler, faster, and more connected experience for care providers and members through Health OS. Health OS is Elevance Health’s secure data platform designed to connect health information across electronic health records (EHRs), labs, and health information exchanges, helping support more informed and timely clinical decisions while reducing administrative burden for care providers. By connecting with healthcare data systems, including Epic’s Payer Platform, Health OS helps reduce manual steps and deliver clearer clinical insights. "Health OS represents a foundational shift in how we app

    6/23/26 8:15:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide

    Strategic investments support more than 40,000 housing units and advance whole health outcomes for communities across the countryElevance Health (NYSE:ELV) today announced it has invested $640 million in affordable housing over the past five years, building on more than $1 billion invested over nearly two decades. These investments reflect the company's continued commitment to addressing social drivers of health, helping lower the total cost of care, and expanding access to safe, stable, and affordable housing.This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260617980738/en/Elevance Health has invested more than $1 billion across ap

    6/17/26 10:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Makes Chronic Care Easier to Navigate With Connected, Personalized Support

    Delivers proactive guidance and coordinated care to help people better manage their health Across the country, three in four adults are living with at least one chronic condition. Elevance Health is helping people manage chronic conditions by creating more personalized, connected experiences that make it easier to understand care, stay on track, and know what to do next. Elevance Health is working to simplify that experience by using data, digital tools, and proactive outreach to connect the people it serves to the support they need when they need it, through services offered through its health plans or its healthcare services business, Carelon. "Managing a chronic condition can be ch

    6/15/26 10:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CAO & Controller Penczek Ronald W sold $148,766 worth of shares (369 units at $403.16), decreasing direct ownership by 9% to 3,740 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    6/15/26 4:10:45 PM ET
    $ELV
    Medical Specialities
    Health Care

    Director Dixon Robert L Jr sold $60,667 worth of shares (151 units at $401.77), decreasing direct ownership by 1% to 10,734 units (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    6/12/26 4:12:50 PM ET
    $ELV
    Medical Specialities
    Health Care

    CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)

    4 - Elevance Health, Inc. (0001156039) (Issuer)

    5/20/26 4:11:33 PM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Financials

    Live finance-specific insights

    View All

    Elevance Health Reports First Quarter 2026 Results; Raises Full-Year Guidance

    1Q 2026 operating revenue of $49.5 billion, up 1.5% from 1Q 2025 1Q 2026 diluted EPS1 of $8.00; adjusted diluted EPS2 of $12.58 driven by strong operating results and ~$1 per share of non-recurring investment income FY 2026 diluted EPS1 guidance to be at least $19.85, including the Company's estimate of the financial impact for the CMS matter FY 2026 adjusted diluted EPS2 guidance raised to at least $26.75, supported by underlying business strength, actions to reduce medical costs, and increased visibility Reaffirm FY 2026 operating cash flow of at least $5.5 billion, inclusive of potential cash payments for the CMS matter Returned $1.5 billion of capital to shareholders in

    4/22/26 6:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2026 Results on April 22, 2026

    Elevance Health (NYSE:ELV) will release first quarter 2026 financial results on April 22, 2026, at 6:00 a.m. Eastern Daylight Time ("EDT"). Management will review these results and its outlook during a conference call at 8:30 a.m. EDT that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers: 888-947-9963 - Access Code - 3972058 (Domestic) 312-470-0178 - Access Code - 3972058 (International) 800-391-9853 - No Access Code (Domestic Replay) 203-369-3269 - No Access Code (International Replay) The call will be available through a live webcast at www.elevancehealth.com under the "Investors" link. You may also acces

    3/30/26 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Reports Fourth Quarter and Full Year 2025 Results; Sets Full Year 2026 Outlook

    4Q 2025 operating revenue of $49.3 billion; FY 2025 of $197.6 billion 4Q 2025 diluted EPS1 of $2.47; adjusted diluted EPS2 of $3.33 FY 2025 diluted EPS1 of $25.21; adjusted diluted EPS2 of $30.29 Projected FY 2026 GAAP diluted EPS1 to be at least $22.30 Projected FY 2026 adjusted diluted EPS2 to be at least $25.50 Returned $4.1 billion of capital to shareholders in 2025 Reaffirming long-term earnings algorithm; recalibrating segment margin targets Elevance Health, Inc. (NYSE:ELV) reported fourth quarter and full year 2025 results. "Elevance Health delivered fourth quarter results in line with our outlook, reflecting disciplined execution in a dynamic environment. As

    1/28/26 6:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Leadership Updates

    Live Leadership Updates

    View All

    Elevance Health Announces Management Changes; CFO Mark Kaye to Expand Responsibilities to Include Carelon and Felicia Norwood to Lead Consolidated Health Benefits Organization

    Elevance Health, Inc. (NYSE:ELV) today announced management changes designed to simplify decision-making and strengthen execution across Carelon and Health Benefits. As part of these changes, Mark Kaye, Executive Vice President and Chief Financial Officer, will expand his responsibilities to include oversight of Carelon, the Company's healthcare services operations including pharmacy services, behavioral health, value-based care, and care delivery capabilities. Carelon plays a critical role in advancing the Company's strategy to lower the cost of care. Carelon's operating priorities and client commitments remain unchanged. Felicia Norwood, Executive Vice President and Chief Health Benef

    2/26/26 3:02:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Board Welcomes Amy Schulman as New Director, Reflecting Ongoing Commitment to Governance Excellence

    The board of directors of Elevance Health (NYSE:ELV) today announced the appointment of Amy Schulman, a recognized healthcare executive, investor, and governance leader, as an independent director, effective January 12, 2026. Schulman will serve on the Audit and Finance Committees, contributing deep expertise in healthcare innovation, regulatory strategy, and value creation across complex, global enterprises. This appointment reflects Elevance Health's ongoing board refreshment strategy to ensure diverse, independent, and future-focused leadership that aligns with the company's long-term strategy and stakeholders' priorities. "Amy's record of driving innovation, disciplined investment, an

    12/10/25 4:30:00 PM ET
    $ELV
    Medical Specialities
    Health Care

    Elevance Health Appoints Nathan Rich Vice President, Investor Relations

    Elevance Health (NYSE:ELV) announced today the appointment of Nathan Rich as Vice President, Investor Relations, effective November 11, 2024. In this role, Mr. Rich will lead Elevance Health's investor relations efforts, providing strategic leadership to support the company's growth initiatives and strengthen relationships within the investment community. He will also serve as a member of the company's executive leadership team and will report directly to Mark Kaye, Executive Vice President and Chief Financial Officer. Mr. Rich succeeds Stephen Tanal, who now serves as Chief Financial Officer for Elevance Health's Government Health Benefits business. "Nate brings nearly two decades of expe

    11/4/24 9:00:00 AM ET
    $ELV
    Medical Specialities
    Health Care

    $ELV
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Elevance Health Inc.

    SC 13G/A - Elevance Health, Inc. (0001156039) (Subject)

    11/14/24 1:22:35 PM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Elevance Health Inc.

    SC 13G - Elevance Health, Inc. (0001156039) (Subject)

    2/14/24 10:02:59 AM ET
    $ELV
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Elevance Health Inc.

    SC 13G - Elevance Health, Inc. (0001156039) (Subject)

    2/14/23 12:37:59 PM ET
    $ELV
    Medical Specialities
    Health Care